week) hemodialysis, left ventricular hypertrophy (LVH)
LVH has been attributed to several factors, including hypertenhas been identified as an independent risk factor for sion, excess extracellular fluid (ECF) volume, anemia and uremia. Nocturnal hemodialysis is a novel renal replacement thermortality [2] . Different authors have estimated the prevapy that appears to improve blood pressure control.
alence of LVH in the general dialysis population at beMethods. This observational cohort study assessed the imtween 70 and 80% [3] . Although the exact pathophysiolpact on LVH of conversion from conventional hemodialysis ogy of LVH in ESRD is unknown, hypertension, poor (CHD) to nocturnal hemodialysis (NHD). In 28 patients (mean age 44 Ϯ 7 years) receiving NHD for at least two years (mean extracellular fluid (ECF) volume control, anemia, and duration 3.4 Ϯ 1.2 years), blood pressure (BP), hemoglobin uremia have been implicated in this process [2, 4] . Nocturnal hemodialysis (NHD), a novel mode of renal and left ventricular mass index (LVMI) were determined bereplacement therapy, provides eight to ten hours of hefore and after conversion. For comparison, 13 control patients (mean age 52 Ϯ 15 years) who remained on self-care home modialysis during sleep six to seven nights per week.
CHD for one year or more (mean duration 2.8 Ϯ 1.8 years)
This mode of dialysis appears to lower blood pressure were studied also. Serial measurements of BP, Hb and LVMI (BP) in dialysis patients [5, 6] , but the reason(s) why were also obtained in this control group. blood pressure falls is unclear. Possible mechanisms inResults. There were no significant differences between the two cohorts with respect to age, use of antihypertensive medicaclude a decrease in ECF volume, vasodilation and abolitions, Hb, BP or LVMI at baseline. After transfer from CHD tion of nocturnal obstructive sleep apnea [7, 8] . Uremia to NHD, there were significant reductions in systolic, diastolic control is superior to that achieved with conventional and pulse pressure (from 145 Ϯ 20 to 122 Ϯ 13 mm Hg, P Ͻ hemodialysis (CHD) [9] . NHD may therefore represent 0.001; from 84 Ϯ 15 to 74 Ϯ 12 mm Hg, P ϭ 0.02; from 61 Ϯ a beneficial alternative mode of renal replacement ther-12 to 49 Ϯ 12 mm Hg, P ϭ 0.002, respectively) and LVMI (from 147 Ϯ 42 to 114 Ϯ 40 g/m 2 , P ϭ 0.004). There was also apy for the ESRD population. In the self-care home dialysis program, each patient received hemodialysis for four hours, three times per week RESULTS via similar vascular access. A dialysate flow rate of 500 to Twenty-eight patients from the NHD cohort and thir-750 mL per minute and F80 polysufone dialyzers were teen patients from the CHD group met these inclusion used.
criteria for analysis. Their baseline demographics are In both cohorts, clinical assessment, including weight, summarized in Table 1 . There was no age difference height, BP and hemoglobin (Hb) concentration was perbetween NHD and CHD cohorts (44 Ϯ 7 vs. 52 Ϯ 15, formed initially and every three months. Parathyroid P Ͼ 0.05). BP was adequately controlled in both groups. hormone (PTH) was measured initially and every six
The interval between the first and last clinic measuremonths. Seated BP was measured during clinic visits by ment was similar (NHD: 3.4 Ϯ 1.2 years vs. CHD: 2.8 Ϯ physicians or nurses after five minutes of rest. All BP 1.8 years, P Ͼ 0.05). Body mass index, BP, antihypertenmeasurements were obtained with the same calibrated sive medication use, Hb and LVH values were similar sphygmomanometer. Echocardiographic data were obin the two groups (Table 1) . tained annually and interpreted blindly.
Primary outcomes are summarized in Table 1 . With Prescribed cardiovascular medications were docu-NHD, there was a significant fall in BP but no change in mented. These included diuretics, beta-blockers, angiopost-dialysis ECF volume. The need for antihypertensive tensin converting enzyme inhibitors, angiotensin receptherapy also decreased yet there were significant reductor antagonists, digitalis, calcium channel blockers, and tions in systolic, diastolic, mean arterial and pulse presvasodilators, were documented. The dose of erythropoisure. There was a significant reduction in LVMI (from etin (EPO) prescribed also was documented.
147 Ϯ 42 g/m 2 to 114 Ϯ 40 g/m 2 , respectively, P ϭ 0.004) In the NHD cohort, ECF volume was estimated by after conversion to nocturnal hemodialysis. At baseline, single-frequency bioelectrical impedance analysis [10] at 7 of 28 (25%) patients in the NHD group and 5 of baseline (prior to conversion) and annually thereafter.
13 (38%) patients in the CHD group had normal left Electrodes were placed on the wrist and foot. Limbs ventricular mass. After conversion to NHD, 20 of 28 with AV access were avoided. The RJL systems device (71%) patients achieved normal left ventricular mass by (model, BIA-101Q; RJL Systems Inc., Clinton TWP, Framingham criteria. In contrast, only 4 of 13 (31%) in MI, USA) with Fluid and Nutrition Analysis Software the CHD group patients had normal left ventricular 3.2 (RJL Systems Inc.) was used to compute ECF volmass. Regression of LVMI was achieved through signifiumes. ECF volume was measured at baseline two to three cant reductions in end-diastolic diameter, septal wall hours after conventional dialysis, and in the morning thickness and posterior wall thickness. At baseline, FS after a regular session of nocturnal hemodialysis.
was similar in the two groups and tended to increase Left ventricular mass was calculated from two-dimenwith long-term NHD. Hb also increased in the NHD sional (2D) echocardiographic images according to the cohort despite a trend toward lower EPO requirements. formula of Devereux and Reichek [11] . The left ventricu-PTH tended to decrease in the NHD cohort. In contrast, lar mass index (LVMI) was derived by correcting the there were no changes in LVMI, BP, Hb, EPO requireleft ventricular mass for a body surface area of 1 m 2 .
ments, PTH or prescription of antihypertensive therapy Left ventricular hypertrophy was defined as LVMI Ͼ131 in the CHD group. g/m 2 in males and Ͼ100 g/m 2 in females, as per the FramThe impact of NHD on LVH regression was detected ingham Study [12] . Fractional shortening (FS), an index by one year and was sustained thereafter (Table 2) . Postof left ventricular systolic function, also was assessed.
dialysis ECF volume was unchanged after conversion to The primary outcome measures were changes in NHD. There were no significant correlations between LVMI, BP, ECF volume and Hb between baseline and changes in LVMI and changes in systolic BP, pulse presthe last recorded value for each cohort. Descriptive analsure, Hb or post-dialysis ECF volume. In the NHD payses are presented as mean Ϯ standard deviation. The tients, there was a significant relationship between the paired Student t test was used for comparison of continufinal LVMI and the final systolic blood pressure (r ϭ ous variables within each cohort. The Student t test was used for comparison of continuous variables between 0.6, P ϭ 0.001; Fig. 1 ). be the principal factor contributing to the regression conclusion. By contrast, CHD, in the present study had a P Ͻ 0.05 vs. baseline no impact on either BP or LVMI.
The absence of significant correlation between changes in LVMI, and changes in either BP, Hb or post-dialysis DISCUSSION ECF volume following conversion to NHD indicates that the pathogenesis of LVH in dialysis patients is likely Dialysis patients with LVH have higher mortality rates multifactorial, and does not depend on the change of than those with normal ventricular mass [13] . In the any unique variable. Changes in ventricular architecture present study, we observed regression of LVH after pain this ESRD population, and reverse remodeling followtients on CHD were converted to NHD. In contrast, LV ing long-term NHD, may provide additional insight into mass did not change in those patients who remained on the relative roles of blood pressure and ECF volume CHD. Conversion to nocturnal dialysis also resulted in expansion mediating these changes. Studies of hypertena clinically important reduction in blood pressure and sive patients with primary hypertension implicate blood in the prescription of antihypertensive therapy.
pressure load in the development of concentric LVH The absence of any significant change in post-dialysis (increased wall thickness with increased LV mass), and in ECF volume, and the strong correlation between the lower addition, increased plasma volume in those with eccen-SBP and LVMI after prolonged NHD, point to a signifitric LVH (normal wall thickness with increased LV cant role for hypertension in the pathogenesis of LVH in mass) [19, 20] . As with previous reports in the ESRD this population. Indeed, in 432 dialysis patients followed population [21] , our patients at baseline had primarily serially, a mean arterial blood pressure of greater than 106 mm Hg was strongly associated with the developeccentric LVH. Following the conversion to NHD, there were significant reductions in both LV wall thickness and fluid status in mediating these BP changes. These authors demonstrated a BP lowering effect of long explain why eccentric hypertrophy was also less promiintermittent HD in the absence of any change in dialysis nent following NHD. It is interesting to note that Leenen ECFV. Nesrallah et al studied ESRD patients who were and colleagues reached a similar conclusion when derandomly assigned to short daily HD or NHD and found scribing the regression of LVH in 18 hypertensive ESRD that BP fell in both groups of patients (abstract; Nespatients after they were placed on chronic ambulatory rallah et al, J Am Soc Nephrol 12:273A, 2001]. However, peritoneal dialysis (CAPD) [22] . Taken together, these post-dialysis ECF volume remained unchanged in the observations suggest that more continuous modes of renocturnal dialysis cohort, in contrast to the short daily nal replacement therapy may promote regression of dialysis cohort in whom there was a fall in post-dialysis LVH likely through augmenting both volume and pres-ECF volume. Parfrey et al have reported significant sure management.
LVMI regression upon resolution of uremia by renal By what mechanism or mechanisms might conversion transplantation in 32 transplant recipients [28] . Thus, the to NHD lower BP? The hypotensive effect of hemodialypresent study adds to the growing evidence that blood sis has been attributed to a reduction in ECF volume pressure control in dialysis patients is not only related [16] . In the Tassin experience, Charzot et al reported to fluid status, but may also arise from superior eliminathat normotension can be achieved by aggressive control tion of vasoactive and trophic substances such as cateof post-dialysis ECF volume [23] . However, our present cholamines or elements of the renin-angiotensin-aldostefindings, which indicate that volume control is not necesrone system. sary for hypotension to occur, are not unique. Savage et Normalization of Hb levels, as noted in the present al studied 27 chronic hemodialysis patients with 48 hours analysis, has been studied previously and found not to of ambulatory BP monitoring between two midweek diincrease BP or affect LV mass [29] . Therefore, the sigalysis sessions [24] . They concluded that interdialytic BP nificant changes observed after the switch to NHD are changes were not related to interdialytic fluid gain, and more likely to arise from the change in dialysis mode than to the increase in Hb. emphasized the importance of additional factors beyond
